RESEARCH-USE BIOSIMILAR ANTIBODY
Zolbetuximab
Monoclonal antibody · IgG1
Zolbetuximab (IMAB362) is a monoclonal antibody targeting Claudin-18.2. Zolbetuximab mediates specific killing of Claudin-18.2-positive cells through immune effector mechanisms. Zolbetuximab can be used for the research of gastrointestinal adenocarcinomas and pancreatic tumors.
TARGETCLDN18.2
YMonoclonal antibody
CATALOGSC-BS-017
CATALOG NUMBERSC-BS-017
MOLECULAR WEIGHTApprox. 147.09 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Zolbetuximab (IMAB362) is a monoclonal antibody targeting Claudin-18.2. Zolbetuximab mediates specific killing of Claudin-18.2-positive cells through immune effector mechanisms. Zolbetuximab can be used for the research of gastrointestinal adenocarcinomas and pancreatic tumors.
Zolbetuximab (IMAB362) is a monoclonal antibody targeting Claudin-18.